Adenovirus infections in patients undergoing bone-marrow transplantation

Insights

Adenovirus infections are common after bone-marrow transplants, particularly species 11, 34, and 35. Graft-versus-host disease significantly increases the risk of severe adenovirus infection and related complications.

Area of Science:

  • Virology
  • Immunology
  • Transplantation Medicine

Background:

  • Viral infections, including adenovirus, are a known complication following bone-marrow transplantation.
  • Certain adenovirus species (subgenus B: types 11, 34, 35) are less common in general populations but have been linked to specific conditions.

Purpose of the Study:

  • To investigate the incidence and characteristics of adenovirus infections in bone-marrow transplant recipients.
  • To identify specific adenovirus species and risk factors associated with infection and severe outcomes.

Main Methods:

  • Retrospective analysis of adenovirus isolates from 1051 bone-marrow transplant patients between 1976 and 1982.
  • Serotyping of adenovirus isolates to determine species.
  • Clinical data review for infection confirmation (biopsy, autopsy) and outcomes.

Main Results:

  • Adenovirus was isolated from 51 patients; 13 isolates were identified as species 11, 34, or 35 (subgenus B), all from patients with positive urine cultures.
  • Invasive infections occurred in 10 patients, with lung involvement (pneumonia) in 7 and fatal outcomes in 4.
  • Renal and hepatic involvement were also observed, and endogenous reactivation was the likely source of infection.
  • Moderate to severe graft-versus-host disease was the primary risk factor for infection and severe disease.

Conclusions:

  • Adenovirus, particularly subgenus B species, can cause significant morbidity and mortality post-bone-marrow transplantation.
  • Graft-versus-host disease is a critical determinant for developing adenovirus infection and its severity in transplant recipients.
  • Endogenous reactivation is a probable mechanism for adenovirus acquisition in this immunocompromised population.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...